Literature DB >> 25806145

Definitive Response to Denniss and Artes: The Paired Eyes and Brain in One Person Are One Unit.

William E Sponsel1, Matthew A Reilly2, Ted Maddess3.   

Abstract

Entities:  

Year:  2015        PMID： 25806145      PMCID： PMC4364494          DOI： 10.1167/tvst.4.2.8

Source DB:  PubMed          Journal:  Transl Vis Sci Technol        ISSN： 2164-2591            Impact factor:   3.283


× No keyword cloud information.
  10 in total

1.  Latanoprost and brimonidine: therapeutic and physiologic assessment before and after oral nonsteroidal anti-inflammatory therapy.

Authors:  William E Sponsel; Gianmarco Paris; Yolanda Trigo; Melanie Pena; Anke Weber; Keith Sanford; Stuart McKinnon
Journal:  Am J Ophthalmol       Date:  2002-01       Impact factor: 5.258

2.  Association of retinal capillary perfusion with visual status during chronic glaucoma therapy.

Authors:  W E Sponsel; P L Kaufman; F G Blum
Journal:  Ophthalmology       Date:  1997-06       Impact factor: 12.079

3.  Extraordinary Claims Require Extraordinary Evidence: Centrally Mediated Preservation of Binocular Visual Field in Glaucoma is Unlikely.

Authors:  Jonathan Denniss; Paul H Artes
Journal:  Transl Vis Sci Technol       Date:  2015-01-22       Impact factor: 3.283

4.  Importance of visual field score and asymmetry in the detection of glaucoma.

Authors:  D Henson; A Hobley; B Chauhan; W Sponsel; N Dallas
Journal:  Am J Optom Physiol Opt       Date:  1986-09

5.  Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma.

Authors:  William E Sponsel; Gianmarco Paris; Yolanda Trigo; Melanie Pena
Journal:  Am J Ophthalmol       Date:  2002-10       Impact factor: 5.258

6.  Effects of latanoprost and timolol-XE on hydrodynamics in the normal eye.

Authors:  W E Sponsel; J Mensah; J W Kiel; A Remky; Y Trigo; W Baca; T Friberg
Journal:  Am J Ophthalmol       Date:  2000-08       Impact factor: 5.258

7.  The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

Authors:  Michael A Kass; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J Philip Miller; Richard K Parrish; M Roy Wilson; Mae O Gordon
Journal:  Arch Ophthalmol       Date:  2002-06

8.  Dorzolamide hydrochloride and visual function in normal eyes.

Authors:  W E Sponsel; J Harrison; W R Elliott; Y Trigo; J Kavanagh; A Harris
Journal:  Am J Ophthalmol       Date:  1997-06       Impact factor: 5.258

9.  Classification of visual field abnormalities in the ocular hypertension treatment study.

Authors:  John L Keltner; Chris A Johnson; Kimberly E Cello; Mary A Edwards; Shannan E Bandermann; Michael A Kass; Mae O Gordon
Journal:  Arch Ophthalmol       Date:  2003-05

10.  Refined Data Analysis Provides Clinical Evidence for Central Nervous System Control of Chronic Glaucomatous Neurodegeneration.

Authors:  William E Sponsel; Sylvia L Groth; Nancy Satsangi; Ted Maddess; Matthew A Reilly
Journal:  Transl Vis Sci Technol       Date:  2014-05-06       Impact factor: 3.283
  10 in total
  2 in total

1.  Nonpenetrating Deep Sclerectomy for Progressive Glaucoma: Long-term (5-year) Follow-up of Intraocular Pressure Control and Visual Field Survival.

Authors:  Grant Slagle; Sylvia L Groth; Mario Montelongo; William E Sponsel
Journal:  J Curr Glaucoma Pract       Date:  2020 Jan-Apr

2.  Pattern Electroretinography and Visual Evoked Potentials Provide Clinical Evidence of CNS Modulation of High- and Low-Contrast VEP Latency in Glaucoma.

Authors:  William E Sponsel; Susan L Johnson; Rick Trevino; Alberto Gonzalez; Sylvia L Groth; Carolyn Majcher; Diane C Fulton; Matthew A Reilly
Journal:  Transl Vis Sci Technol       Date:  2017-11-08       Impact factor: 3.283
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.